Global Oncolytic Virus Market Size, Share, Trends and Forecast 2022-2030

Description

An oncolytic virus is a virus that preferentially infects and kills cancer cells. As the infected cancer cells are destroyed by oncolysis, they release new infectious virus particles or virions to help destroy the remaining tumor. Oncolytic Virus Therapy is an exciting, increasingly recognized discipline in cancer research. Although the connection between viruses and cancer regression was recognized in the early 20th century, it wasn't until the recent development of advanced genetic engineering techniques that true progress has been made using virotherapy to attack and destroy cancer cells. Today, researchers can modify existing viruses to create new oncolytic viruses that are less susceptible to immune suppression while more specifically targeting particular classes of cancer cells. Additionally, these modified oncolytic viruses can be adapted to insert and express cancer-suppressing genes and diagnostic proteins.
Industry Insights

Due to the COVID-19 pandemic, the global Oncolytic Virus market size is estimated to be worth US$ 17 million in 2021 and is forecast to a readjusted size of US$ 27 million by 2028 with a CAGR of 6.8% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Oncolytic Virus market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Oncolytic Virus landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

To date, two genetically engineered oncolytic viruses have been approved for marketing as drugs. One is Oncorine (H101, the same construct as ONYX‐015),9 an E1B‐deleted adenovirus, which was approved in China for head and neck cancer and esophagus cancer in 2005. The use and clinical data of Oncorine is so far limited to China. The other is T‐Vec (talimogene laherparepvec, IMLYGIC, formerly OncoVEXGM‐CSF), which was approved for melanoma by the FDA in the USA in October 2015 and was subsequently approved in Europe in January 2016 and in Australia in May 2016. For developing product, there are 3 products in Phase 3, 8 products in Phase 2, 7 products in Phase 1 and 3 products in Preclinical. Market competition is intense. Amgen, Shanghai Sunway Biotech, Oncolytics Biotech, Viralytics, Transgene SA are the leading developers in the industry; with high investment in research marketing and they will monopoly position in the industry. Other players include Oncolys BioPharma, Targovax, PsiOxus Therapeutics, SillaJen Biotherapeutics, Sorrento Therapeutics, Lokon Pharma, Genelux Corporation, Vyriad, TILT Biotherapeutics and Cold Genesys, etc.

This report focuses on Oncolytic Virus volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Oncolytic Virus market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Australia, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Oncolytic Virus market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Imlygic

Oncorine

Others

Segment by Application

Melanoma

Other Cancers

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

U.S.

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Indonesia

Thailand

Malaysia

Philippines

Vietnam

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Amgen

Shanghai Sunway Biotech

TABLE OF CONTENT

1 Oncolytic Virus Market Overview
1.1 Product Overview and Scope of Oncolytic Virus

1.2 Oncolytic Virus Segment by Type

1.2.1 Global Oncolytic Virus Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Imlygic

1.2.3 Oncorine

1.2.4 Others

1.3 Oncolytic Virus Segment by Application

1.3.1 Global Oncolytic Virus Sales Comparison by Application: (2022-2028)

1.3.2 Melanoma

1.3.3 Other Cancers

1.4 Global Oncolytic Virus Market Size Estimates and Forecasts

1.4.1 Global Oncolytic Virus Revenue 2017-2028

1.4.2 Global Oncolytic Virus Sales 2017-2028

1.4.3 Oncolytic Virus Market Size by Region: 2017 Versus 2021 Versus 2028

2 Oncolytic Virus Market Competition by Manufacturers

2.1 Global Oncolytic Virus Sales Market Share by Manufacturers (2017-2022)

2.2 Global Oncolytic Virus Revenue Market Share by Manufacturers (2017-2022)

2.3 Global Oncolytic Virus Average Price by Manufacturers (2017-2022)

2.4 Manufacturers Oncolytic Virus Manufacturing Sites, Area Served, Product Type

2.5 Oncolytic Virus Market Competitive Situation and Trends

2.5.1 Oncolytic Virus Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Oncolytic Virus Players Market Share by Revenue

2.5.3 Global Oncolytic Virus Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Oncolytic Virus Retrospective Market Scenario by Region

3.1 Global Oncolytic Virus Retrospective Market Scenario in Sales by Region: 2017-2022

3.2 Global Oncolytic Virus Retrospective Market Scenario in Revenue by Region: 2017-2022

3.3 North America Oncolytic Virus Market Facts & Figures by Country

3.3.1 North America Oncolytic Virus Sales by Country

3.3.2 North America Oncolytic Virus Revenue by Country

3.3.3 U.S.

3.3.4 Canada

3.4 Europe Oncolytic Virus Market Facts & Figures by Country

3.4.1 Europe Oncolytic Virus Sales by Country

3.4.2 Europe Oncolytic Virus Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Oncolytic Virus Market Facts & Figures by Region

3.5.1 Asia Pacific Oncolytic Virus Sales by Region

3.5.2 Asia Pacific Oncolytic Virus Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.5.12 Philippines

3.5.13 Vietnam

3.6 Latin America Oncolytic Virus Market Facts & Figures by Country

3.6.1 Latin America Oncolytic Virus Sales by Country

3.6.2 Latin America Oncolytic Virus Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Oncolytic Virus Market Facts & Figures by Country

3.7.1 Middle East and Africa Oncolytic Virus Sales by Country

3.7.2 Middle East and Africa Oncolytic Virus Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Oncolytic Virus Historic Market Analysis by Type

4.1 Global Oncolytic Virus Sales Market Share by Type (2017-2022)

4.2 Global Oncolytic Virus Revenue Market Share by Type (2017-2022)

4.3 Global Oncolytic Virus Price by Type (2017-2022)

5 Global Oncolytic Virus Historic Market Analysis by Application

5.1 Global Oncolytic Virus Sales Market Share by Application (2017-2022)

5.2 Global Oncolytic Virus Revenue Market Share by Application (2017-2022)

5.3 Global Oncolytic Virus Price by Application (2017-2022)

6 Key Companies Profiled

6.1 Amgen

6.1.1 Amgen Corporation Information

6.1.2 Amgen Description and Business Overview

6.1.3 Amgen Oncolytic Virus Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Amgen Oncolytic Virus Product Portfolio

6.1.5 Amgen Recent Developments/Updates

6.2 Shanghai Sunway Biotech

6.2.1 Shanghai Sunway Biotech Corporation Information

6.2.2 Shanghai Sunway Biotech Description and Business Overview

6.2.3 Shanghai Sunway Biotech Oncolytic Virus Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Shanghai Sunway Biotech Oncolytic Virus Product Portfolio

6.2.5 Shanghai Sunway Biotech Recent Developments/Updates

7 Oncolytic Virus Manufacturing Cost Analysis

7.1 Oncolytic Virus Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Oncolytic Virus

7.4 Oncolytic Virus Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

8.1 Marketing Channel

8.2 Oncolytic Virus Distributors List

8.3 Oncolytic Virus Customers

9 Oncolytic Virus Market Dynamics

9.1 Oncolytic Virus Industry Trends

9.2 Oncolytic Virus Market Drivers

9.3 Oncolytic Virus Market Challenges

9.4 Oncolytic Virus Market Restraints

10 Global Market Forecast

10.1 Oncolytic Virus Market Estimates and Projections by Type

10.1.1 Global Forecasted Sales of Oncolytic Virus by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Oncolytic Virus by Type (2023-2028)

10.2 Oncolytic Virus Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Oncolytic Virus by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Oncolytic Virus by Application (2023-2028)

10.3 Oncolytic Virus Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Oncolytic Virus by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Oncolytic Virus by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

12.4 Disclaimer

Choose License Type

Checkout Inquiry Sample